Show simple item record

dc.contributor.authorRead, Graham R
dc.contributor.authorRobertson, A Gerald
dc.contributor.authorBlair, Val
dc.date.accessioned2014-12-22T15:15:24Z
dc.date.available2014-12-22T15:15:24Z
dc.date.issued1983-07
dc.identifier.citationRadiotherapy in seminoma of the testis. 1983, 34 (4):469-73 Clin Radiolen
dc.identifier.issn0009-9260
dc.identifier.pmid6409494
dc.identifier.doi10.1016/S0009-9260(83)80251-7
dc.identifier.urihttp://hdl.handle.net/10541/337539
dc.description.abstractFive hundred and forty-seven patients with histologically proven seminoma of the testis were treated by radiotherapy between 1960 and 1978 using a standard method. Of these, 448 patients had 'early' disease and a life-table survival of 94% at 5 years was achieved. Survival was significantly improved in patients treated in later time periods. Survival in more advanced disease was less good (62% in Stage IIB, 51% in Stage III and 13% in Stage IV at 5 years). The radiotherapeutic management of this tumour is discussed.
dc.language.isoenen
dc.rightsArchived with thanks to Clinical radiologyen
dc.subject.meshDysgerminoma
dc.subject.meshHumans
dc.subject.meshLymphatic Metastasis
dc.subject.meshMale
dc.subject.meshNeoplasm Recurrence, Local
dc.subject.meshNeoplasm Staging
dc.subject.meshRadiotherapy Dosage
dc.subject.meshRadiotherapy, High-Energy
dc.subject.meshTesticular Neoplasms
dc.titleRadiotherapy in seminoma of the testis.en
dc.typeArticleen
dc.contributor.departmentDepartments of Radiotherapy and Medical Statistics, The Christie Hospital and Holt Radium Institute, Manchesteren
dc.identifier.journalClinical Radiologyen
html.description.abstractFive hundred and forty-seven patients with histologically proven seminoma of the testis were treated by radiotherapy between 1960 and 1978 using a standard method. Of these, 448 patients had 'early' disease and a life-table survival of 94% at 5 years was achieved. Survival was significantly improved in patients treated in later time periods. Survival in more advanced disease was less good (62% in Stage IIB, 51% in Stage III and 13% in Stage IV at 5 years). The radiotherapeutic management of this tumour is discussed.


Files in this item

This item appears in the following Collection(s)

Show simple item record